A1 milk with the a1 beta-casein variant is a possible risk factor in the development of type 1 diabetes in children, autism, and heart illnesses in adults.
Milos Pokimica
Written By: Milos Pokimica
Medically Reviewed by: Dr. Xiùying Wáng, M.D.
Updated June 10, 2023Key Takeaways:
– Beta-casein is a protein that makes up about 30% of the protein in cow’s milk. It exists in two genetic variants: A1 and A2.
– A1 beta-casein in cow milk is different from all other mammals, which exclusively have A2 type including A2 cattle from India, and Africa, Buffalo, as same as other mammals and the same as human milk. Almost all cattle of the A1 type are related to cows of European origin for the subspecies of the original species of this mutation Bos Taurus.
– BCM7 is a peptide that breaks down from A1 beta-casein into 7 amino acids. It has opiate-like effects similar to narcotics such as morphine and can be harmful to low-density lipoproteins (LDL).
– There is a correlation between type 1 diabetes and antibodies to A1 beta-casein. These antibodies are believed to attack the cells that produce insulin in the pancreas due to similarities with BCM7’s protein structure.
– Casomorphins are opioids that can be found in dairy products, specifically in A1 beta-casein. They have been linked to autism and schizophrenia through the “opioid excess” theory
– Opioid peptides from cows’ milk have long been theorized as a possible cause of sudden infant death syndrome (SIDS), as they may inhibit the respiratory center in the brainstem, leading to apnea and death.
– Elevated basal irBCM (cattle casomorphins) was found in formula-fed infants showing a delay in psychomotor development and heightened muscle tone while the highest basal irHCM (human casomorphins) was observed in breast-fed infants with normal psychomotor development and muscle tone.
A1 beta-casein in cow milk.
Beta-casein is about 30% of the protein in cow’s milk. Beta-casein is present as one or two genetic variants; A1 or A2. Most cow’s milk contains a combination of A1 and A2 beta-casein. However, milk that contains only the A2 type without A1 beta-casein alpha is available in some countries.
The second variant, A2 beta-casein, is not associated with diabetes type 1.
The established relationship of this link between A1 beta-casein and type 1 diabetes, and heart disease is 0.982 and 0.76 (Laugesen and Elliott, 2003).
This is a very significant level if compared with other epidemiological reasons for these conditions, such as smoking and mortality from lung cancer r = 0.73 or the likelihood of people in the 1960s and heart conditions ten years later where r = 0.85.
The difference between A1 and A2 beta-casein is present because of a single amino acid substitution at 67 line of amino acids of 209 that they have in the chain.

A1 beta-casein in cow milk is different from all other mammals, which exclusively have A2 type including A2 cattle from India, and Africa, Buffalo, as same as other mammals and the same as human milk. Almost all cattle of the A1 type are related to cows of European origin for the subspecies of the original species of this mutation Bos Taurus.

It is a result of a genetic mutation in cows in Europe that happened about 8,000 years ago. Today, A1 milk cows are bred in Europe and America, and A2 species are bred in New Zeeland. Holstein species have A1 and A2 beta-casein in almost equal amounts. The Jersey species typically has a little more than A2 but is also considered a mixed species. The same Jersey cows carry a “B” beta-casein that has proven to give more BCM7. Signs of poor histidine attachment, A1 beta-casein breaks down into peptides of 7 amino acids called beta casomorphin 7 (BCM7) when consumed. BCM7 is problematic because opiate is at the same level as narcotics like morphine and has similar effects. It is also an oxidant that is known to be detrimental to low-density lipoproteins (LDL). Because the links between 7 amino acids make it extremely strong, it is resistant to further degradation. When BCM7 enters the bloodstream, various problems arise.

However, the BCM 7 is too large to be absorbed by a healthy coat in the intestine, which means that the health problem associated with A1 beta-casein is more likely to be affected by people with damaged digestive health or from diseases such as celiac disease or gastrointestinal disease.
If you have a leaky gut, then you can give yourself and your fetus if you are pregnant type 1 diabetes as an autoimmune disease. if you consume milk and dairy products, that is. Persons having any of the prevailing conditions are more suitable for abscess BCM7. In babies that naturally have increased intestinal permeability in order to improve the absorption of nutrients, there is a higher risk also.
Once it enters the bloodstream, BCM7 can easily break through the blood-brain barrier and enter the brain, where the connection to the receptors causes the symptoms of autism and schizophrenia.
This claim was initiated by research that was disseminated on rats, where rats showed similar tendencies in behavior and sympathy as autism and schizophrenia after BCM7 injection. The association of these effects was also confirmed by the ability to reverse the state and changes in opioid-antagonistic naloxone behavior. To add to that, it has long been recognized that opiates have an effect on immune function, which is the possible reason why A1 beta-casein and BCM7 are associated with autoimmune diseases.
Heart Disease.
The first discovery was made by Alexandra Steinerovathat have been investigating the reasons behind oxidative stress in infants. She discovered that babies who were fed milk formula had a higher level of antibodies to oxidized LDL (Steinerová et al, 1999). In 2004, Steinerova put forth the idea and did a study on BCM7 and the increase in antibodies in infants. A study demonstrated that infants fed A1 beta-casein baby formula developed significantly higher levels of these antibodies compared to that fed A2 beta-casein (Steinerová et al., 2004).
Today more research had been done and it is excepted in the scientific community that BCM7 has a pro-oxidative effect on LDL. In the case of cardiac diseases, additional studies have uncovered the mechanism by which the A1 beta-casein will develop the cardiac disease, and the primary effect is a BCM7 that oxidizes LDL that transports cholesterol from the liver to the tissues (Chin-Dusting et al., 2006). This is important because the oxidized LDL increases the risk of heart disease as a result of increased artery incidence and as a consequence increased plaque accumulation, ie. oxidized LDL makes arteries sticky and leads to the formation of plaque.
Type 1 Diabetes.
Type 1 diabetes, is classified as an autoimmune disease that occurs due to an immune system assault on cells that produce insulin in the pancreas.
And it is not genetic as you might lead to believe by conventional medicine. Genetic predisposition plays a role but to prove the fact that it is just one more maladaptation we can look at identical twins. The concordance of diabetes type 1 in identical twins is only 50 %. Meaning one gets it one does not. If it is genetic and the environment does not play a role that would not happen. It is something we ate or to be precise mothers ate or give the babies that cause them to develop this autoimmune disease.
In Japan diabetes type 1 is 18 times lower than in the U.S., but when the Japanese migrate to America and start to adopt the Western diet, they develop the same rate of diabetes as Americans. Some countries have 100 times the less diabetes type 1 rates than others depending mostly on the diet the population eats. Type one diabetes started to rise after World War 2 as same as other diseases, so it is not genetics. It is maladaptation, and we now know what is causing it.

In 1999 scholars in Germany discovered that there is a correlation between type 1 diabetes and the level of antibodies to A1 beta-casein. It is believed that these antibodies are, in fact, based on the amino acid sequence of the problematic opioid BCM7, which is derived from A1 beta-casein. Because the sequence has similarities with the protein structure of the cells that produce insulin in the pancreas, the antibodies attack the pancreas together with the BCM7 peptides. In this study, every single kid had significant levels of A1 beta-casein antibodies in their blood but not of antibodies to other milk proteins (Karjalainen et al., 1992). The conclusion was:
“Patients with insulin-dependent diabetes mellitus have immunity to cows milk albumin, with antibodies to an albumin peptide that is capable of reacting with a beta-cell-specific surface protein. Such antibodies could participate in the development of islet dysfunction.”
Karjalainen et al., 1992

Autism, Schizophrenia, and Sudden Infant Death Syndrome.
Also, there are opiates that cross the blood-brain barrier. Because BCM7 opiates should not be present at all and represent a form of unnatural mutation in cattle it should not be a great surprise in the relationship between A1 beta-casein and casein in general to association with autism also.



BCM 7 obtained from A1 beta-casein and gluteomorphin derived from gluten are both opiates that can be associated with these symptoms. Because of this, a huge number of children with autism show significant improvements if they avoid gluten and casein. The relationship between autism and opiates is nothing new. In 1979, Jaak Panksepp, a scientist, suggested that connection. In 2000, a team of researchers led by Robert Cade reviewed the existing evidence linking the casein and gluten opiates with autism and schizophrenia. They collected new data from 150 autistic children, 120 schizophrenia adults, 43 normal children, and 76 normal adults (Cade et al., 2000). Autistic children and schizophrenia adults showed a constant elevated abnormal value of casomorphin and gluteomorphin opioid peptides obtained from beta-casein and gluten.
Actually, all adults show elevated levels of this morphine opioid substance after consumption of milk or yogurt, even the adult that does not have inflammation in the gut at least for 8 hours after consumption (Chabance et al., 1998).
The theory goes something like this. You have a genetic predisposition for diseases such as autism or schizophrenia. This is the so-called “opioid excess” theory. You have a genetic predisposition and then have some early exposure to environmental stressors that damage your gut and make it leaky or you are just a regular baby that naturally has a leaky gut. Then comes the milk or dairy products with all of the casomorphins leaking into the blood in excess and then into the brain triggering disease to form. These opioids are thought that could play one of the roles in the development of autism and other neurological disorders. The problem with these casomorphins is also that when you examine the blood-brain barrier of autism patients, their blood-brain barrier seems weaker too.
In a normal individual, there are going to be some of the sedative effects but in someone with a leaky gut and a leaky blood-brain barrier it is going to have a much stronger effect, and if that person has a genetic predisposition or sensitivity to it then the real disease can form. By the so-called “opioid excess” theory anyway.
Of the seventy autistic children placed on a gluten-free and casein-free diet, 81% showed significant improvements over a period of 3 months, and more than a third of those who did not recover were still high in opioid peptides, indicating that they did not keep the child’s diet. Although only 40% of adults have improved, it is believed that many of them have not been using the diet for long enough to provide their bodies with the ability to eliminate existing BCM7 molecules in the brain that can last for more than a year.
In 1999, Zhongjie Sun and Robert Cade injected BCM7 opioid derivatives from A1 beta-casein into rats to determine if it enters the brain (Cade et al., 1999). They found out that it will enter the various areas of the brain that were previously proven to be associated with autism and schizophrenia. As a consequence, it was reasoned that the BCM7 could break through a blood-brain barrier and hit parts of the brain that are susceptible to those affected by autism and schizophrenia. In the same year, they conducted a similar experiment and found that rats injected with BCM7 exhibited several significant symptoms of autism and schizophrenia such as intolerance, reduced pain sensitivity, and lack of response to external stimuli.
In 2003, Sun and Cade continued their research and discovered that gluteomorphin opioids derived from gluten affect only three regions of the brain while BCM7 opioids derived from A1 beta-casein affected 45 regions and circulation of this peptide into the infant’s immature central nervous system might also inhibit the respiratory center in the brainstem leading to apnea and death (Sun et al, 2003). Opioid peptides from milk have long been theorized as a possible cause of sudden infant death syndrome (Ramabadran and Bansinath, 1988).
This not only proved that BCM7 comes to the brain much more easily but it is a much larger factor in the development of autism and schizophrenia. Are these studies going to lead to more understanding or better treatment of these individuals I do not know. There could be individuals with a genetic predisposition to these diseases that these molecular mimicry proteins only aggravate. I don’t know. Science still doing research but it is a slow process and who will have the interest to finance these studies? It will take some time.
Opoid casomorphins and psychomotor delay.
A1 milk vs A2 milk got a big political issue in Australia and New Zeeland at one point. It ended with obligatory labeling of milk and all dairy products. In Australia, you cannot buy a bottle of A1 milk or any other dairy product without a visible label that shows does the milk contain an A1 or A2 form of protein.

Why are these opioids in the milk in the first place? And there are in all of the milk in existence, not just the A1 milk variant. A1 milk is just a more potent variant. For normal human babies as well as calves, they are there to create a craving or to get them addicted like regular drug addicts are, but in this case, the addiction is going to trigger the baby’s curing for opiates and then the baby is going to get all the nutrition from milk that it needs to grow. It is all as it should be but now we have switched species. Just like the protein amino acid profile of human and cow milk is not the same so the profile of these casomorphins is not the same.
In this study (Kost et al., 2009) the babies fed on cow’s milk with a higher level of bovine casomorphins seem to suffer from psychomotor delay but exactly the reverse was found for human casomorphins. Human casomorphins seams to help the brain of humans. The conclusion of the study was:
“The highest basal irHCM (human casomorphins) was observed in breast-fed infants with normal psychomotor development and muscle tone. In contrast, elevated basal irBCM (cattle casomorphins) was found in formula-fed infants showing a delay in psychomotor development and heightened muscle tone. Among formula-fed infants with normal development, the rate of this parameter directly correlated to basal irBCM. The data indicate that breastfeeding has an advantage over artificial feeding for infants development during the first year of life and support the hypothesis for the deterioration of bovine casomorphin elimination as a risk factor for delay in psychomotor development and other diseases such as autism.”
(Kost et al., 2009)
The structure of casein in human and cow milk is significantly different matching only by 47%, and especially if we have mutated A1 casein in the mix, then we have a situation that can trigger diabetes type 1 in the baby. Bovine casomorphin is much stronger than human one, and it is almost at the level of morphine in its effect (Trivedi et al., 2015). Cow casomorphins bind tighter to the serotonin receptors in the brain than human one does. Also, opioid casomorphins were produced by both A1 and A2 milk with no difference in potency (Asledottir et al., 2017). Also, there is much more casein in general in cow’s milk, 15 times more to be precise than in human’s milk. Twenty-one peptides and eight from beta-casein were found in cow milk, and only five peptides with only one from beta-casein were found in human milk.

Should you switch to A2 which is ten times more expensive? What about pizza with A1 milk cheese or any other commercial A1 milk product? Most of the chocolates are made with A1 milk powder. The most realistic scenario is that even if we want to switch to A2 there is no A2 milk around if you live outside of New Zeeland. And even in New Zeeland, there is the chipset powder A1 milk made for the food industry in almost everything. From ice cream to chocolate. And even if we could spend additional money and have that A2 ice cream, milk is still correlated including A2 to a wide range of health issues (Milk and dairy- Health risk correlations).
The Devil in Milk, Why It Can be Dangerous.
FAQ
References:
- Karjalainen, J., Martin, J. M., Knip, M., Ilonen, J., Robinson, B. H., Savilahti, E., Akerblom, H. K., & Dosch, H. M. (1992). A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. The New England journal of medicine, 327(5), 302–307. https://doi.org/10.1056/NEJM199207303270502
- Chabance, B., Marteau, P., Rambaud, J. C., Migliore-Samour, D., Boynard, M., Perrotin, P., Guillet, R., Jollès, P., & Fiat, A. M. (1998). Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie, 80(2), 155–165. https://doi.org/10.1016/s0300-9084(98)80022-9
- Kost, N. V., Sokolov, O. Y., Kurasova, O. B., Dmitriev, A. D., Tarakanova, J. N., Gabaeva, M. V., Zolotarev, Y. A., Dadayan, A. K., Grachev, S. A., Korneeva, E. V., Mikheeva, I. G., & Zozulya, A. A. (2009). Beta-casomorphins-7 in infants on different type of feeding and different levels of psychomotor development. Peptides, 30(10), 1854–1860. https://doi.org/10.1016/j.peptides.2009.06.025
- Trivedi, M. S., Hodgson, N., Walker, S. G., Trooskens, G., Nair, V., & Deth, R. C. (2015). Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells. Nutrition & Metabolism, 12(1). https://doi.org/10.1186/s12986-015-0050-1
- Asledottir, T., Le, T. T., Petrat-Melin, B., Devold, T. G., Larsen, L. B., & Vegarud, G. E. (2017). Identification of bioactive peptides and quantification of β-casomorphin-7 from bovine β-casein A1, A2 and I after ex vivo gastrointestinal digestion. International Dairy Journal, 71, 98-106. https://doi.org/10.1016/j.idairyj.2017.03.008
- Cade, R., Privette, M., Fregly, M., Rowland, N., Sun, Z., Zele, V., Wagemaker, H., & Edelstein, C. (2000). Autism and Schizophrenia: Intestinal Disorders. Nutritional neuroscience, 3(1), 57–72. https://doi.org/10.1080/1028415X.2000.11747303
- Pal, S., Woodford, K., Kukuljan, S., & Ho, S. (2015). Milk Intolerance, Beta-Casein and Lactose. Nutrients, 7(9), 7285-7297. https://doi.org/10.3390/nu7095339
- Chia, J. S. J., McRae, J. L., Kukuljan, S., Woodford, K., Elliott, R. B., Swinburn, B., & Dwyer, K. M. (2017). A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes. Nutrition & diabetes, 7(5), e274. https://doi.org/10.1038/nutd.2017.16
- Sun, Z., Zhang, Z., Wang, X., Cade, R., Elmir, Z., & Fregly, M. (2003). Relation of beta-casomorphin to apnea in sudden infant death syndrome. Peptides, 24(6), 937–943. https://doi.org/10.1016/s0196-9781(03)00156-6
- Ramabadran, K., & Bansinath, M. (1988). Opioid peptides from milk as a possible cause of sudden infant death syndrome. Medical hypotheses, 27(3), 181–187. https://doi.org/10.1016/0306-9877(88)90138-7
- Chin-Dusting, J., Shennan, J., Jones, E., Williams, C., Kingwell, B., & Dart, A. (2006). Effect of dietary supplementation with beta-casein A1 or A2 on markers of disease development in individuals at high risk of cardiovascular disease. The British journal of nutrition, 95(1), 136–144. https://doi.org/10.1079/bjn20051599
- Steinerová, A., Racek, J., Stozický, F., Tatzber, F., & Lapin, A. (1999). Autoantibodies against oxidized LDL in the first phase of life. Low density lipoproteins. Clinical chemistry and laboratory medicine, 37(9), 913–917. https://doi.org/10.1515/CCLM.1999.135
- Steinerová, A., Korotvicka, M., Racek, J., Rajdl, D., Trefil, L., Stozický, F., & Rokyta, Z. (2004). Significant increase in antibodies against oxidized LDL particles (IgoxLDL) in three-month old infants who received milk formula. Atherosclerosis, 173(1), 147–148. https://doi.org/10.1016/j.atherosclerosis.2003.12.006
- Laugesen, M., & Elliott, R. (2003). Ischaemic heart disease, Type 1 diabetes, and cow milk A1 beta-casein. The New Zealand medical journal, 116(1168), U295. [PubMed]
Related Posts
Do you have any questions about nutrition and health?
I would love to hear from you and answer them in my next post. I appreciate your input and opinion and I look forward to hearing from you soon. I also invite you to follow us on Facebook, Instagram, and Pinterest for more diet, nutrition, and health content. You can leave a comment there and connect with other health enthusiasts, share your tips and experiences, and get support and encouragement from our team and community.
I hope that this post was informative and enjoyable for you and that you are prepared to apply the insights you learned. If you found this post helpful, please share it with your friends and family who might also benefit from it. You never know who might need some guidance and support on their health journey.
– You Might Also Like –

Learn About Nutrition
Milos Pokimica is a doctor of natural medicine, clinical nutritionist, medical health and nutrition writer, and nutritional science advisor. Author of the book series Go Vegan? Review of Science, he also operates the natural health website GoVeganWay.com
Medical Disclaimer
GoVeganWay.com brings you reviews of the latest nutrition and health-related research. The information provided represents the personal opinion of the author and is not intended nor implied to be a substitute for professional medical advice, diagnosis, or treatment. The information provided is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH GoVeganWay.com
NEVER APPLY ANY LIFESTYLE CHANGES OR ANY CHANGES AT ALL AS A CONSEQUENCE OF SOMETHING YOU HAVE READ IN GoVeganWay.com BEFORE CONSULTING LICENCED MEDICAL PRACTITIONER.
In the event of a medical emergency, call a doctor or 911 immediately. GoVeganWay.com does not recommend or endorse any specific groups, organizations, tests, physicians, products, procedures, opinions, or other information that may be mentioned inside.
Editor Picks –
Milos Pokimica is a doctor of natural medicine, clinical nutritionist, medical health and nutrition writer, and nutritional science advisor. Author of the book series Go Vegan? Review of Science, he also operates the natural health website GoVeganWay.com
Latest Articles –
Plant Based News
-
Under Armour Launches Compostable Plant-Based Sportswear
on April 14, 2025
-
‘My Chili Crisp Caesar Pasta Salad Went Viral – Here’s How To Make It’
on April 14, 2025
-
‘4 Oil-Free Vegan Recipes I Can’t Stop Eating’
on April 13, 2025
-
TiNDLE’s Plant-Based Chicken Launches At Hundreds Of New US Stores
on April 13, 2025
-
‘The Foods I Eat To Get Enough Iron In My Plant-Based Diet’
on April 13, 2025
-
‘The Huge Plant-Based Costco Deals You Don’t Want To Miss’
on April 12, 2025
-
Plant-Based Diets Could Reduce Risk Of Certain Blood Clots, Study Finds
on April 12, 2025
Top Health News — ScienceDaily
- Driving the CAR to fight acute myeloid leukemiaon April 11, 2025
A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team identified a monoclonal antibody called KG2032 that reacts with a certain variant of the HLA-DRB1 molecule. KG2032 CAR T cells displayed strong anti-AML effects in a mouse model, and CAR natural killer cells showed similar results. Clinical trials are currently being planned.
- New strategy may enable cancer monitoring from blood tests aloneon April 11, 2025
A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a new study. The method, based on whole-genome sequencing of DNA, also represents an important step toward the goal of routine blood test-based screening for early cancer detection.
- Genes in bacterial genomes are arranged in a meaningful orderon April 10, 2025
Bioinformaticians have established that the genes in bacterial genomes are arranged in a meaningful order. They describe that the genes are arranged by function: If they become increasingly important at faster growth, they are located near the origin of DNA replication. Accordingly, their position influences how their activity changes with the growth rate.
- Researchers put glycemic response modeling on a data dieton April 10, 2025
Data-sparse method opens door to personalized nutrition — without the stool samples.
- Better tools when searching for genetic causes of asthmaon April 10, 2025
A new study combines genetic data and improved computational tools to look more closely at GWAS results for both adult-onset and childhood-onset asthma. The research identified many genetic variants with a high likelihood of having a causal effect on both types of asthma, paving the way for further studies to target the genes connected to these variants as potential treatments.
- Unsafe driving during school drop offs at ‘unacceptable’ levelson April 10, 2025
Risky driving by parents and other motorists who do the school run is putting children in danger, according to a new study.
- Research team improves method for producing designer proteinson April 10, 2025
Why do problems occur with a special variant of ‘protein glues’, the split inteins, that severely limit their use in producing proteins? A team has now answered this question.
PubMed, #vegan-diet –
- Plant-Based Culinary Medicine Intervention Improves Cooking Behaviors, Diet Quality, and Skin Carotenoid Status in Adults at Risk of Heart Disease Participating in a Randomized Crossover Trialon April 12, 2025
Background: Culinary medicine (CM) interventions in teaching kitchens have emerged as novel approaches for influencing dietary behaviors, but their efficacy, content, and delivery vary. Objective: The effects of a virtual vegan CM intervention on behavioral determinants, cooking competencies, diet quality, and skin carotenoid status were assessed. Methods: This analysis from a 9-week randomized crossover study evaluated behavioral survey assessments, Whole Plant Food Density (WPFD) as a diet…
- The Influence of Vegan, Vegetarian, and Omnivorous Diets on Protein Metabolism: A Role for the Gut-Muscle Axis?on April 12, 2025
There has been a growing interest globally in vegan and vegetarian diets over the last decade for a combination of health, ethical, environmental, spiritual, and social reasons. In line with this popularity, research examining the role of plant-based food sources, including vegan and vegetarian diets, in supporting skeletal muscle remodeling and anabolism in humans has also received considerable attention. The emergence of the microbiota-gut-muscle axis, a bidirectional pathway where the gut…
- Correction: The Impact of a Vegan Diet on Many Aspects of Health: The Overlooked Side of Veganismon April 11, 2025
[This corrects the article DOI: 10.7759/cureus.35148.].
- Are plant-based and omnivorous diets the same for muscle hypertrophy? A narrative review of possible challenges of plant-based diets in resistance-trained athleteson April 11, 2025
This narrative review examines the potential challenges associated with plant-based diets in supporting muscle hypertrophy among resistance-trained athletes. Contrary to common assumptions, current evidence suggests that plant-based diets, when properly planned, can provide protein comparable to omnivorous diets. However, plant-based proteins are generally considered less anabolic due to lower digestibility, essential amino acid (EAA) content, and particularly lower leucine levels. The review…
- Veganism during pregnancy: Exploring experiences and needs of women following a plant-based dieton April 10, 2025
CONCLUSIONS: This study highlighted the confidence and pride pregnant vegans may experience, but also the challenges they face due to social stigma, misconceptions, cravings and nausea, and the need for better information and support. By addressing these challenges, healthcare professionals and communities can contribute to healthier and more informed vegan pregnancies, ultimately benefiting the well-being and health of both mothers and their infants.
Random Posts –
Featured Posts –

Latest from PubMed, #plant-based diet –
- Adherence to a Mediterranean diet and leisure-time physical activity are associated with reduced initiation of antidepressant, anxiolytic, antipsychotic and antiseizure drug use in older adults: a…by Marta H Hernandez on April 13, 2025
CONCLUSIONS: MedDiet and LTPA adherence reduced psychoactive drugs initiation in older adults.
- Plant-based diets and mortality in Black and low-income Americans: Findings from a large prospective cohort studyby Fangcheng Yuan on April 13, 2025
CONCLUSIONS: Adherence to a diet characterized by healthy plant foods and low animal foods may decrease mortality.
- Interrelations of Leptin and Interleukin-6 in Vitamin D Deficient and Overweight Orthodox Nuns from Northern Greece: A Pilot Studyby Spyridon N Karras on April 12, 2025
Background/Objectives: Athonian fasting, a rigorous form of intermittent fasting practiced by Christian Orthodox nuns and a subset of the Mediterranean diet, has known health benefits, but its impact on the interplay of adipokines, inflammatory cytokines, and vitamin D status remains under-investigated. This study aimed to elucidate these relationships within this controlled dietary context. Methods: This cross-sectional study examined the interplay of leptin, interleukin-6 (IL-6), and vitamin […]
- Nutritional Quality, Safety and Environmental Benefits of Alternative Protein Sources-An Overviewby Anna Choręziak on April 12, 2025
Protein is a fundamental macronutrient in the human diet. It supplies our organisms with essential amino acids, which are needed for the growth and maintenance of cells and tissues. Conventional protein sources, despite their complete amino acid profiles and excellent digestibility, have a proven negative impact on the environment. Furthermore, their production poses many ethical challenges. This review aims to present nutritional, more ethical, and environmentally friendly alternatives that…
- Plant-Based Diet Indices with Greenhouse Gas Emissions and Risk of Cardiometabolic Diseases and All-Cause Mortality: Longitudinal China Cohort Studyby Yiqian Lv on April 12, 2025
Background: Environmental and cardiometabolic impacts of adherence to plant-based dietary patterns with different quality are unclear. Objectives: To investigate the associations between adherence to the overall, healthy, and unhealthy plant-based dietary patterns, as assessed by the plant-based diet index (PDI), healthy PDI (hPDI), and unhealthy PDI (uPDI), respectively, and risk of myocardial infarction (MI), type 2 diabetes (T2D), stroke, and all-cause mortality and greenhouse gas (GHG)…
- Adherence to the Mediterranean Diet Among Families from Four Countries in the Mediterranean Basinby Ozge Yesildemir on April 12, 2025
Background/Objectives: The cultural and socioeconomic changes to which societies are exposed can alter individuals’ lifestyles and dietary habits. The nutritional patterns of Mediterranean countries may also be affected by these factors at varying levels, depending on the changing social characteristics of the countries. This study aimed to determine Mediterranean diet (MedDiet) adherence among family members from four Mediterranean countries (Türkiye, Spain, Italy, and Lebanon). Methods: […]